The invention
Establishment of DNA replication-initiation proteins as novel anticancer targets (drips) and development of first-in-class anticancer drug candidates targeting drips
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- C73
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- Established DNA replication-initiation proteins (DRIPs) as novel anticancer targets and identified DRIP inhibitors as potent broad-spectrum anticancer drug candidates without harm to normal cells; one is safe and effective in phase II clinical trial.
- Simplified description
- Scientists have discovered that DNA replication-initiation proteins (DRIPs) can be targeted to fight cancer. New inhibitors of DRIPs show promise as strong anticancer drugs that don't harm healthy cells. One of these drugs is performing well and safely in phase II clinical trials.
Inventors
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
inventor 3700652863_2972
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.